Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Gigantomastia in Australia
Total 0 results
Nothing found
Sponsors and Collaborators
Prader-Willi Syndrome Association of Australia
Health Holding Company, Hail Health Cluster, Saudi Arabia
Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
Resurge Therapeutics Inc.
wenbinlu
Kettering Foundation
Sociedad Española de Arteriosclerosis
Australian Childhood Foundation
Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
Paul W. Read, MD
Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
Epicentre, Paris, France.
Sonogenix
Remedy Institute
Carlos III Health Institute
Brigham and Womens' Hospital, Center for Surgery and Public Health
NATURAmedicatrix Sàrl
The Depressive and Bipolar Disorder Alternative Treatment Foundation
Laboratoires Iprad-Vegebom
Zhijun Sun
View Full List
Medical Conditions
Pregnancy; Accident
Escape Room Games and Role Playing Gamification
Apneic; Oxygenation
Stage IIIB Esophageal Adenocarcinoma
Mycobacterium Avium Complex Infections
Spinocerebellar Ataxia Genotype Type 3
Stroke Recrudescence
Lymphoblastic Lymphoma
Malignant Tumor of Extrahepatic Bile Duct
Ankle Trauma
Hernia,Ventral
Stage III Childhood Anaplastic Large Cell Lymphoma
Cell Senescence
Refractory B-Lineage Lymphoma
Intervention Studies
Neurobehavioral Manifestation
Adherence to In-Office Glaucoma Evaluation Appointment
Psychoactive Substance Use
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Marginal Zone B-cell Lymphoma
View Full List
Drug Interventions
Gadoteridol (ProHance)
Optiva artificial tear by Allergan
Everolimus
ART-123
Lansoprazole 15mg QD
Epalrestat
Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
Low molecular weight Heparin as standard of care treatment
FRSW107
Oral Aztreonam
LINjeta U-100 Insulin
SBI-087
Triple therapy
Colecalciferol D3 (Vigantol Oil)
Fenofibric acid 135mg
Fostamatinib
Omeprazole 40 mg
Irinotecan
300 mg of caffeine citrate infusion
View Full List
CROs by country
Contract Research Organizations in Dominican Republic
Contract Research Organizations in Finland
Contract Research Organizations in France
Contract Research Organizations in Georgia
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Kosovo
Contract Research Organizations in Kuwait
Contract Research Organizations in Kyrgyzstan
Contract Research Organizations in Mauritania
Contract Research Organizations in Saudi Arabia
Contract Research Organizations in Taiwan
Contract Research Organizations in Tunisia
Contract Research Organizations in Zambia
CRO list by country
CROs in Latvia
OCT Clinical
Accell Clinical Research
Medfiles
SGS
IRIS CRO
Syneos Health
ICON
PPD
SanaClis
Dokumeds
All CROs in Latvia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe